Abiopharma

New Form 4 - Enliven Therapeutics, Inc. Filed: 2025-07-01 AccNo: 0001415889-25-018718 Size: 11 KB

New Form 8-K - Foghorn Therapeutics Inc. Filed: 2025-07-01 AccNo: 0001628280-25-033784 Size: 23 MB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

New Form 3 - ABBOTT LABORATORIES Filed: 2025-07-01 AccNo: 0001415889-25-018716 Size: 12 KB

New Form 8-K - Dyne Therapeutics, Inc. Filed: 2025-07-01 AccNo: 0001193125-25-154057 Size: 475 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

New Form SCHEDULE 13G - Pyxis Oncology, Inc. Filed: 2025-07-01 AccNo: 0001104659-25-064765 Size: 15 KB

New Form 4 - American Well Corp Filed: 2025-07-01 AccNo: 0000950170-25-092279 Size: 5 KB

New Form 144 - Simulations Plus, Inc. Filed: 2025-07-01 AccNo: 0001950047-25-004790 Size: 6 KB

New Form 4 - American Well Corp Filed: 2025-07-01 AccNo: 0000950170-25-092278 Size: 4 KB

New Form 144 - American Well Corp Filed: 2025-07-01 AccNo: 0000950170-25-092274 Size: 6 KB

New Form 144 - Warby Parker Inc. Filed: 2025-07-01 AccNo: 0001950047-25-004780 Size: 4 KB

New Form 4 - Climb Bio, Inc. Filed: 2025-07-01 AccNo: 0000950170-25-092273 Size: 24 KB

New Form 4 - LEAP THERAPEUTICS, INC. Filed: 2025-07-01 AccNo: 0001104659-25-064756 Size: 3 KB

New Form 144 - BridgeBio Pharma, Inc. Filed: 2025-07-01 AccNo: 0001950047-25-004775 Size: 6 KB

New Form 144 - BridgeBio Pharma, Inc. Filed: 2025-07-01 AccNo: 0001950047-25-004774 Size: 4 KB

New Form 8-K - Outlook Therapeutics, Inc. Filed: 2025-07-01 AccNo: 0001104659-25-064755 Size: 306 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits